Commerzbank Aktiengesellschaft FI Has $201,000 Stock Position in Cardinal Health, Inc. $CAH

Commerzbank Aktiengesellschaft FI reduced its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 92.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 1,196 shares of the company’s stock after selling 14,859 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Cardinal Health were worth $201,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its stake in shares of Cardinal Health by 28.4% in the first quarter. GAMMA Investing LLC now owns 7,004 shares of the company’s stock valued at $965,000 after acquiring an additional 1,549 shares during the last quarter. Assenagon Asset Management S.A. increased its holdings in Cardinal Health by 25.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company’s stock valued at $1,811,000 after purchasing an additional 2,694 shares in the last quarter. CX Institutional raised its position in Cardinal Health by 20.7% in the 1st quarter. CX Institutional now owns 2,722 shares of the company’s stock valued at $375,000 after purchasing an additional 466 shares during the last quarter. Fifth Third Bancorp boosted its stake in Cardinal Health by 5.4% in the first quarter. Fifth Third Bancorp now owns 14,190 shares of the company’s stock worth $1,955,000 after purchasing an additional 732 shares in the last quarter. Finally, Fort Washington Investment Advisors Inc. OH increased its stake in shares of Cardinal Health by 0.8% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 11,981 shares of the company’s stock valued at $1,651,000 after buying an additional 98 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Insider Activity

In other news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the transaction, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. This represents a 44.00% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CAH. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday. Leerink Partners increased their price target on shares of Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a research note on Monday, October 6th. Argus set a $189.00 price objective on shares of Cardinal Health in a research report on Friday, August 22nd. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Finally, Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research note on Tuesday, August 12th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $166.00.

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $156.86 on Friday. Cardinal Health, Inc. has a 52 week low of $106.98 and a 52 week high of $168.44. The stock has a market capitalization of $37.27 billion, a price-to-earnings ratio of 24.32, a PEG ratio of 1.33 and a beta of 0.71. The firm has a fifty day moving average of $152.09 and a two-hundred day moving average of $151.21.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the prior year, the company posted $1.84 earnings per share. The firm’s revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.